Microkpro Medical

Microkpro Medical is a China-based ophthalmic medical device company focused on artificial vision and corneal disease treatment. The company develops and manufactures artificial cornea products, with its lead and apparently core commercial product being the MIOK Keratoprosthesis, a 100% non-biological artificial cornea intended for patients with corneal blindness. The product was approved for listing in China in December 2021 and is positioned for patients who have failed corneal transplantation or are at high risk of graft failure. Microkpro emphasizes synthetic polymer-based corneal replacement technology that avoids co-implantation of donor corneas, addressing donor shortage and immune rejection issues associated with traditional transplantation. The company appears to operate manufacturing facilities in Beijing and has clinical and hospital ties in China for ophthalmic application of its devices.